Editor-in-Chief: Gian Paolo Andreoletti, MD

Connecting Specialists Worldwide

Senology, official website of the International Senologic and Oncologic Scientific Community,  is now curator of the Breast Cancer section on ResearchGate.

Join us on  ResearchGate,  LinkedIn,  Doctorsbook, Twitter, Facebook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions. Check out Senology.org Newspaper and follow our RSS feeds for real-time updates

Literature Selection

• Tafreshi NK et al.: "Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes", Clin Cancer Res. 2012 Jan 1;18(1):207-19
• Park S et al.: "Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers", Breast Cancer Res Treat. 2012 Jan 10. [Epub ahead of print]
• Baselga J et al.: "Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial", Lancet. 2012 Jan 16. [Epub ahead of print]
• Bear HD et al.: "Bevacizumab added to neoadjuvant chemotherapy for breast cancer", N Engl J Med. 2012 Jan 26;366(4):310-20
• von Minckwitz G et al.: "Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer", N Engl J Med. 2012 Jan 26;366(4):299-309
• Lange SA et al.: "Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy", Clin Res Cardiol. 2012 Jan 17. [Epub ahead of print]
• Dubsky PC et al.: "Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group", J Clin Oncol. 2012 Jan 23. [Epub ahead of print]
• Chadha M et al.: "Comparative Acute Toxicity from Whole Breast Irradiation Using 3-Week Accelerated Schedule With Concomitant Boost and the 6.5-Week Conventional Schedule With Sequential Boost for Early-Stage Breast Cancer", Clin Breast Cancer 2012 Feb; 12(1).57-62
• Hymas RV et al.: "Is Short-Interval Mammography Necessary after Breast Conservation Surgery and Radiation Treatment in Breast Cancer Patients?", Int J Radiat Oncol Biol Phys. 2012 Jan 13. [Epub ahead of print]

Discussion

•   - "Need of a Ki67 in histopathology report?" - Share your opinion on  LinkedIn

Calendar of Events

• 2nd International Congress of Breast Disease Centers, February 9-10. 2012, Paris, France
• 3rd Asian Breast Cancer Congress, March 3-4, 2012, Bangalore, India
• 29th Annual Miami Breast Cancer Conference, March 14-17, 2012, Miami, FL, USA
• 8th European Breast Cancer Conference, March 21-24, 2012, Vienna, Austria

Fragments of History

• William S Halsted  (New York, 1852-1922),  "The results of radical operations  for the cure of carcinoma of the breast", Ann Surg. July 1907:46(1):1-19: “The Operation - Though the area of disease extend from cranium to knee, breast cancer in the broad sense is a local affection, and there comes to the surgeon an encouragement to greater endeavor with the cognition that the metastases to bone, to pleura, to liver, are probably parts of the whole, and that the involvements are almost invariably by process of lymphatic permeation and not embolic by way of the blood"  

Literature Selection

• Currie CJ et al.: "Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival", Diabetes Care. 2012 Jan 20. [Epub ahead of print]
• Kushi LH et al.: "American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity", CA Cancer J Clin. 2012 Jan;62(1):30-67
• Ruf CG et akl.: "Predicting metastasized seminoma using gene expression", BJU Int. 2012 Jan 13 [Epub ahead of print]
• Chen SF et al.: "Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association", J Oral Pathol Med. 2012 Jan;41(1):9-15
• Bolton K et al.: "Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer", JAMA. 2012 Jan 25;307(4):382-90
• Coleman HG et al.: "Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's Esophagus", Gastroenterology. 2012 Feb;142(2):233-40
• Kantor ED et al.: "Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus", Cancer Epidemiol Biomarkers Prev. 2012 Jan 20. [Epub ahead of print]
• Cardoso R et al.: "What is the accuracy of sentinel lymph node biopsy for gastric cancer? A systematic review", Gastric Cancer. 2012 Jan 20. [Epub ahead of print]
• Sanoff HK et al.: "Comparative Effectiveness of Oxaliplatin vs Non-Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer", J Natl Cancer Inst. 2012 Jan 20. [Epub ahead of print]
• Tsan YT et al.: "Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection", J Clin Oncol. 2012 Jan 23. [Epub ahead of print]
• Larsson SC et al.: "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies", Br J Cancer. 2012 Jan 12 [Epub ahead of print]
• Bodmer M et al.: "Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case-Control Analysis", Am J Gastroenterol. 2012 Jan 31 [Epub ahead of print]
• Meyer RM et al.: "ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma", N Engl J Med. 2012 Feb 2;366(5):399-408
• Shen X et al.: "The Impact of Brachytherapy on Prostate Cancer-Specific Mortality for Definitive Radiation Therapy of High-Grade Prostate Cancer: A Population-Based Analysis", Int J Radiat Oncol Biol Phys. 2012 Jan 21. [Epub ahead of print]
• Fleshner NE et al.: "Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial", Lancet. 2012 Jan 23. [Epub ahead of print]

Comment

• "Resection margin for patients with cutaneous melanoma",  Peter Gillgren, Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden
   
  ""Clinicians today can be safer when they decide to treat patients with thick melanomas (>2mm) with a 2-cm excisional margin. In a randomised controlled multicentre trial from Karolinska Institute, 936 patients were allocated to either a 2-cm (465) or a 4-cm (471) margin. There were no differences in overall survival nor in recurrence free survival. Patients were followed 6,7 years."
  (Comment on:  Gillgren P et al.: "2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial", Lancet. 2011 Nov 5;378(9803):1635-42)

Literature Selection

• Chao C et al.: "Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine", J Intern Med. 2012 Feb;271(2):193-203
• Donnez J et al.: "Ulipristal acetate versus leuprolide acetate for uterine fibroids", N Engl J Med. 2012 Feb 2;366(5):421-32
• Donnez J et al.: "Ulipristal acetate versus placebo for fibroid treatment before surgery", N Engl J Med. 2012 Feb 2;366(5):409-20